Effect of a Specialized Oral Supplement on Nutritional Status and Quality of Life in Non-dialysis CKD (NCT06576479)
Validation of the Therapeutic Effect and Safety of a Specialized Oral Supplement on the Nutritional Status and Quality of Life in Patients with Chronic Kidney Disease Without Replacement Therapy: (Grade G3a, G3b, G4 and G5)
🩺 Plain-English Summary (8th-Grade Level)
Patients whit chronic kidney disease (CKD) there is a high prevalence of nutritional disorders and negative changes in body composition, which is strongly associated with an increased risk of morbidity and mortality.
Who can join: Review the eligibility criteria below.
Location: Hospital Civil Fray Antonio Alcalde — Guadalajara, Jalisco
Age range: 18 Years to 90 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Hospital Civil Fray Antonio Alcalde — Guadalajara, Jalisco
📞 Contact the Study Coordinator
Phone: 011 52 3320587471
Email: paola.alvarado@nin.com.mx
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Chronic Kidney Diseases
- Evaluation of Increased Fruits and Vegetables Consumption in Chronic Kidney Disease — Port Jefferson Station, New York
- Combination of Novel Therapies for CKD Comorbid Depression — Stony Brook, New York
- Reducing Dietary Acid With Food Versus Oral Alkali in People With Chronic Kidney Disease (ReDACKD) — Winnipeg, Manitoba
- Developing Tools for Dialysis Decision Support — Palo Alto, California
- BRINK (BRain In Kidney Disease) Memory Study 2.0 — Minneapolis, Minnesota
- Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease — Chicago, Illinois
Explore by condition: All Chronic Kidney Diseases clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.